Last reviewed · How we verify

NCT03125681

Remote Ischemic Conditioning and Platelet Dysfunction

Completed NA Last updated 4 April 2019
What this trial tests

NA trial testing Remote ischemic conditioning in Platelet Function in 58 participants. Completed in 9 February 2019.

Timeline
11 May 2017
Primary endpoint
31 January 2019
9 February 2019

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment58
Start date11 May 2017
Primary completion31 January 2019
Estimated completion9 February 2019
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Adults 20 to 80, any sex, with Platelet Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the effects of remote ischemic conditioning on platelet function during off-pump coronary artery bypass surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Remote ischemic conditioning

Trials testing the same drug.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03125681.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing